Release Date: 22/02/13 18:11 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 645.11KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%